#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinism Cortical dysplasia Porphyria non-acute Pleomorphic leiomyosarcoma Myxoid liposarcoma Systemic candida Prostate cancer PIK3CA-activated mutation Juvenile idiopathic arthritis Infantile apnoea ABO haemolytic disease of newborn Chronic cutaneous lupus erythematosus Acute myeloid leukaemia recurrent Arrhythmogenic right ventricular dysplasia Cutaneous T-cell lymphoma More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Trials in Disease Combined immunodeficiency – Trials in Disease Nephrotic syndrome – Basic Information Retinoblastoma – Trials in Disease Hepatoblastoma – Life with Disease Angiosarcoma metastatic Glomerulonephritis rapidly progressive – Diagnostics Osteosarcoma recurrent Hereditary ataxia Marginal zone lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Linerixibat Plasma (-)-PHENSERINE TARTRATE Peboctocogene Camaparvovec Cldn6 Car-T Pegfilgrastim AB521 Benzylpenicillin Nido-361 BENZYDAMINE HYDROCHLORIDE Glibenclamide Desvenlafaxine Benzoate Vismodegib COBALAMIN Zongertinib Dexchlorpheniramine Maleate Sodium Hypochlorite Epoetin Alfa Tazobactam AZD1163 More therapies…

    Learn about Your Condition

    Dizziness Acute myocardial infarction Invasive breast carcinoma Pleural mesothelioma malignant Mechanical ventilation Wiskott-Aldrich syndrome Oesophageal achalasia Craniosynostosis Huntington's disease Knee arthroplasty Stevens-Johnson syndrome Supranuclear palsy Indolent systemic mastocytosis Fatty acid oxidation disorder HER2 positive breast cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on 18F-FES PET/MRI for Patients with Luminal A and Lobular Breast Cancer to Improve Treatment Decisions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Italy

  • Study on the Safety of Continuing Apixaban, Clopidogrel, and Rivaroxaban During Polyp Removal in Patients on Antiplatelet or Anticoagulant Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • Lactose Monohydrate
    • Telmisartan
    Spain

  • Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine with aura
    • Migraine without aura
    • Migraine
    Investigated Drugs:
    • Rimegepant
    Poland Spain Sweden

  • Study on High-Dose Methylprednisolone and Prednisolone for Children with Stroke Due to Focal Cerebral Arteriopathy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Prednisolone Metasulfobenzoate Sodium
    • Betamethasone Sodium Phosphate
    Austria Denmark France Germany Sweden

  • Study on the Long-term Safety of Guselkumab for Children with Crohn’s Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    Belgium France Germany Italy Norway Poland +2

  • Study on the Safety and Effectiveness of MK-2870 Alone or with Other Drugs for Patients with Colorectal, Pancreatic, and Biliary Tract Cancers

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Colorectal cancer
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Calcium Folinate
    • Cisplatin
    Italy Spain
Previous Page
1 … 521 522 523 524 525 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!